Colgate-Palmolive Officer Files Form 144 for $1.97M Option Exercise Sale
COLGATE PALMOLIVE CO
Subscribe to track CL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Notice: COLGATE PALMOLIVE CO ($CL) • Insider: Panagiotis Tsourapas (Officer) • Proposed Sale: 19,938 shares Common Stock (~$1,968,709.79) • Estimated Price: ~$98.74 • Source: Exercise of employee stock options (Broker assisted cashless exercise) • Approx. Date of Sale: 11/04/2026 • Broker: Merrill Lynch
Comprehensive Analysis
Executive Summary
On November 4, 2026, Panagiotis Tsourapas, an Officer at Colgate-Palmolive Co ($CL), filed a Form 144 notification of the proposed sale of 19,938 shares of Common Stock, with an aggregate market value of approximately $1,968,709.79 (implied price of ~$98.74 per share).
Transaction Details
- Acquisition Origin: The securities being sold were acquired on November 4, 2026, through the exercise of employee stock options via a broker-assisted cashless exercise.
- Broker: Merrill Lynch.
- Prior Dispositions: The filing notes an earlier sale within the prior three months: 10,000 shares sold on August 24, 2026, for gross proceeds of $920,477.17.
Market Impact & Significance
This proposed transaction carries Low market significance. It represents a routine option exercise and sale by an officer, representing a negligible fraction (<0.01%) of Colgate-Palmolive's 794,920,513 outstanding shares.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.